ADMA Biologics Inc

Historical 13F Holders

Symbol
ADMA
CUSIP
000899104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 000899104 since 12/18/2024, newest first.

Filer % of Class Filed
State Street Corp 13G
7.4% 8/7/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 5.1% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 4 0% 3/26/2026
Event 3/13/2026
Invesco Ltd. 13G/A Amendment 1 5.0%
Checked 5% or less
2/12/2026
Event 12/31/2025
State Street Corp 13G 5.1% 8/11/2025
Event 6/30/2025
Vanguard Group Inc 13G/A Amendment 3 8.9% 7/29/2025
Event 6/30/2025
State Street Corp 13G 4.8% 5/13/2025
Event 3/31/2025
Invesco Ltd. 13G 5.4% 5/9/2025
Event 3/31/2025
BlackRock, Inc. 13G/A Amendment 3 15.1% 4/30/2025
Event 3/31/2025
Invesco Ltd. 13G/A Amendment 1 4.8% 2/7/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 34 553 k $5.40 M
2026 Q2 342 208 M $1.97 B
2026 Q1 375 212 M $1.91 B
2025 Q4 377 220 M $4.02 B
2025 Q3 389 220 M $3.28 B
2025 Q2 393 213 M $3.87 B
2025 Q1 367 207 M $4.09 B
2024 Q4 336 204 M $3.50 B
2024 Q3 319 209 M $4.17 B
2024 Q2 263 186 M $2.08 B
2024 Q1 224 183 M $1.21 B
2023 Q4 193 175 M $790 M
2023 Q3 197 171 M $613 M
2023 Q2 188 165 M $611 M
2023 Q1 170 166 M $549 M
2022 Q4 172 164 M $635 M
2022 Q3 140 131 M $319 M
2022 Q2 120 119 M $236 M
2022 Q1 113 105 M $190 M
2021 Q4 106 111 M $156 M
2021 Q3 84 41.8 M $47.3 M
2021 Q2 104 59.5 M $95.2 M
2021 Q1 120 65.1 M $115 M
2020 Q4 110 45.5 M $89.6 M
2020 Q3 107 46.2 M $110 M
2020 Q2 102 49.4 M $145 M
2020 Q1 96 48.5 M $140 M
2019 Q4 79 33.2 M $133 M
2019 Q3 78 37.2 M $165 M
2019 Q2 76 35.3 M $137 M
2019 Q1 61 22.3 M $84.5 M
2018 Q4 54 25.0 M $58.6 M
2018 Q3 62 26.8 M $166 M
2018 Q2 56 25.6 M $115 M
2018 Q1 34 17.0 M $78.0 M
2017 Q4 23 17.0 M $54.7 M
2017 Q3 20 9.02 M $27.8 M
2017 Q2 19 8.91 M $33.2 M
2017 Q1 20 9.24 M $45.1 M
2016 Q4 19 9.38 M $48.0 M
2016 Q3 20 9.63 M $69.7 M
2016 Q2 28 9.52 M $57.4 M
2016 Q1 23 8.39 M $67.9 M
2015 Q4 26 8.42 M $68.0 M
2015 Q3 24 7.05 M $58.9 M
2015 Q2 24 7.03 M $65.1 M
2015 Q1 19 6.95 M $68.1 M
2014 Q4 13 5.98 M $66.8 M
2014 Q3 1 777 k $8.00 M
2014 Q2 1 667 k $6.50 M